{"id":15519,"date":"2011-04-15T08:23:44","date_gmt":"2011-04-15T12:23:44","guid":{"rendered":"http:\/\/asweetlife.org\/?p=15519"},"modified":"2015-12-29T08:39:37","modified_gmt":"2015-12-29T13:39:37","slug":"victoza-more-effective-than-competitors-new-study-shows","status":"publish","type":"post","link":"https:\/\/asweetlife.org\/?p=15519","title":{"rendered":"Victoza More Effective Than Competitors New Study Shows"},"content":{"rendered":"<p style=\"text-align: justify;\"><a href=\"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/04\/NovoNordiskLogo.png\" rel=\"mfp\"><img decoding=\"async\" class=\"alignleft size-full wp-image-15530 lazyload\" title=\"NovoNordiskLogo\" src=\"data:image\/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==\" data-src=\"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/04\/NovoNordiskLogo.png\" alt=\"\" width=\"151\" height=\"112\" \/><\/a>A new meta study presented by Novo Nordisk at the 20th Annual Meeting and Clinical Congress of the American Association of Clinical Endocrinologists (AACE) shows that regardless of baseline A1C, once-daily Victoza (liraglutide [rDNA origin] injection) 1.8 mg consistently helped more patients achieve blood sugar control than some other commonly used type 2 diabetes therapies.<\/p>\n<p style=\"text-align: justify;\">The study determined that all diabetes therapies improved blood sugar control across all baseline A1C categories, with greater reductions at higher baseline A1C levels as compared to placebo (added to background therapy). The greatest reductions were observed in the Victoza group and ranged from 0.7% in the less than or equal to 7.5% category to 1.8% in the &gt;9.0% category.<\/p>\n<p style=\"text-align: justify;\">Victoza reductions were followed by insulin glargine (Lantus) and exenatide (Byetta). \u00a0Patients taking Januvia (sitagliptin) experienced no reduction in the less than or equal to 7.5% category to 1.1% in the &gt;9.0% category. Patients taking sulfonylureas had a 0.4%-1.4% reduction. Patients treated with thiazolidinediones (TZDs like Avandia and Actos) had the narrowest margin of reduction, from 0.4% in the less than or equal to 7.5% category to 0.8% in the &gt;9.0% category.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A new meta study presented by Novo Nordisk at the 20th Annual Meeting and Clinical Congress of the American Association of Clinical Endocrinologists (AACE) shows that regardless of baseline A1C, once-daily Victoza (liraglutide [rDNA origin] injection) 1.8 mg consistently helped more patients achieve blood sugar control than&#8230;<\/p>\n","protected":false},"author":131,"featured_media":15530,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1443],"tags":[315],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.9 (Yoast SEO v22.9) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Victoza More Effective Than Competitors New Study Shows<\/title>\n<meta name=\"description\" content=\"Victoza reductions were followed by insulin glargine (Lantus) and exenatide (Byetta). Patients taking Januvia (sitagliptin) experienced no reduction to 1.1%.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/asweetlife.org\/?p=15519\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ASweetLife Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/asweetlife.org\/?p=15519\",\"url\":\"https:\/\/asweetlife.org\/?p=15519\",\"name\":\"Victoza More Effective Than Competitors New Study Shows\",\"isPartOf\":{\"@id\":\"https:\/\/asweetlife.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/asweetlife.org\/?p=15519#primaryimage\"},\"image\":{\"@id\":\"https:\/\/asweetlife.org\/?p=15519#primaryimage\"},\"thumbnailUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/04\/NovoNordiskLogo.png\",\"datePublished\":\"2011-04-15T12:23:44+00:00\",\"dateModified\":\"2015-12-29T13:39:37+00:00\",\"author\":{\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585\"},\"description\":\"Victoza reductions were followed by insulin glargine (Lantus) and exenatide (Byetta). Patients taking Januvia (sitagliptin) experienced no reduction to 1.1%.\",\"breadcrumb\":{\"@id\":\"https:\/\/asweetlife.org\/?p=15519#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/asweetlife.org\/?p=15519\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/?p=15519#primaryimage\",\"url\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/04\/NovoNordiskLogo.png\",\"contentUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/04\/NovoNordiskLogo.png\",\"width\":215,\"height\":160,\"caption\":\"NovoNordiskLogo\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/asweetlife.org\/?p=15519#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/asweetlife.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Victoza More Effective Than Competitors New Study Shows\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/asweetlife.org\/#website\",\"url\":\"https:\/\/asweetlife.org\/\",\"name\":\"ASweetLife\",\"description\":\"The Diabetes Magazine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/asweetlife.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585\",\"name\":\"ASweetLife Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g\",\"caption\":\"ASweetLife Team\"},\"url\":\"https:\/\/asweetlife.org\/?author=131\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Victoza More Effective Than Competitors New Study Shows","description":"Victoza reductions were followed by insulin glargine (Lantus) and exenatide (Byetta). Patients taking Januvia (sitagliptin) experienced no reduction to 1.1%.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/asweetlife.org\/?p=15519","twitter_misc":{"Written by":"ASweetLife Team","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/asweetlife.org\/?p=15519","url":"https:\/\/asweetlife.org\/?p=15519","name":"Victoza More Effective Than Competitors New Study Shows","isPartOf":{"@id":"https:\/\/asweetlife.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/asweetlife.org\/?p=15519#primaryimage"},"image":{"@id":"https:\/\/asweetlife.org\/?p=15519#primaryimage"},"thumbnailUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/04\/NovoNordiskLogo.png","datePublished":"2011-04-15T12:23:44+00:00","dateModified":"2015-12-29T13:39:37+00:00","author":{"@id":"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585"},"description":"Victoza reductions were followed by insulin glargine (Lantus) and exenatide (Byetta). Patients taking Januvia (sitagliptin) experienced no reduction to 1.1%.","breadcrumb":{"@id":"https:\/\/asweetlife.org\/?p=15519#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/asweetlife.org\/?p=15519"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/?p=15519#primaryimage","url":"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/04\/NovoNordiskLogo.png","contentUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/04\/NovoNordiskLogo.png","width":215,"height":160,"caption":"NovoNordiskLogo"},{"@type":"BreadcrumbList","@id":"https:\/\/asweetlife.org\/?p=15519#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/asweetlife.org\/"},{"@type":"ListItem","position":2,"name":"Victoza More Effective Than Competitors New Study Shows"}]},{"@type":"WebSite","@id":"https:\/\/asweetlife.org\/#website","url":"https:\/\/asweetlife.org\/","name":"ASweetLife","description":"The Diabetes Magazine","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/asweetlife.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585","name":"ASweetLife Team","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g","caption":"ASweetLife Team"},"url":"https:\/\/asweetlife.org\/?author=131"}]}},"_links":{"self":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/15519"}],"collection":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15519"}],"version-history":[{"count":0,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/15519\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/media\/15530"}],"wp:attachment":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15519"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15519"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15519"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}